Şendur MAN - Search Results

1

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study).

Hizal M, Bilgin B, Paksoy N, Atcı MM, Kahraman S, Kılıçkap S, Güven DC, Keskinkılıç M, Ayhan M, Eren Ö, Mustafayev FNA, Yaman Ş, Bayram E, Ertürk İ, Özcan E, Korkmaz M, Akagündüz B, Erdem D, Telli TA, Aksoy A, Üskent N, Baytemür NK, Gülmez A, Aydın D, Şakalar T, Arak H, Tatlı AM, Ergün Y, Ak N, Ünal Ç, Özgün MA, Yalçın B, Öztop İ, Algın E, Sakin A, Aydıner A, Yumuk PF, Şendur MAN. Hizal M, et al. Among authors: sendur man. J Cancer Res Clin Oncol. 2023 Jul;149(8):4141-4148. doi: 10.1007/s00432-022-04252-2. Epub 2022 Sep 1. J Cancer Res Clin Oncol. 2023. PMID: 36048274

2

Demographic and clinico-pathological characteristics of breast cancer patients with history of oral alendronate use.

Sendur MA, Aksoy S, Yaman S, Arık Z, Özdemir NY, Zengin N, Altundağ K. Sendur MA, et al. Med Oncol. 2012 Dec;29(4):2601-5. doi: 10.1007/s12032-012-0209-9. Epub 2012 Mar 15. Med Oncol. 2012. PMID: 22418852

3

Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy.

Kos FT, Sendur MA, Aksoy S, Celik HT, Sezer S, Civelek B, Yaman S, Zengin N. Kos FT, et al. Asian Pac J Cancer Prev. 2013;14(2):1111-4. doi: 10.7314/apjcp.2013.14.2.1111. Asian Pac J Cancer Prev. 2013. PMID: 23621196 Free article.

4

Serum 25-hydroxy vitamin D status is not related to osteopenia/osteoporosis risk in colorectal cancer survivors.

Akinci MB, Sendur MA, Aksoy S, Yazici O, Ozdemir NY, Kos T, Yaman S, Altundag K, Zengin N. Akinci MB, et al. Asian Pac J Cancer Prev. 2014;15(8):3377-81. doi: 10.7314/apjcp.2014.15.8.3377. Asian Pac J Cancer Prev. 2014. PMID: 24870725 Free article.

5

Flurbiprofen-induced unilateral eyelid angioedema.

Sendur MA, Aksoy S, Ozdemir NY, Yaman S, Zengin N. Sendur MA, et al. Cutis. 2014 Oct;94(4):E12-3. Cutis. 2014. PMID: 25372261 No abstract available.

6

Expectations of response from octreotide therapy in recurrent phosphaturic mesenchymal tumors--do they reflect reality?

Ulas A, Dede DS, Sendur MA, Akinci MB, Yalcin B. Ulas A, et al. Asian Pac J Cancer Prev. 2014;15(24):10997-8. doi: 10.7314/apjcp.2014.15.24.10997. Asian Pac J Cancer Prev. 2014. PMID: 25605218 Free article. No abstract available.

7

Do statins really improve colorectal cancer-specific mortality?

Şendur MA, Aksoy S, Yalçın B. Şendur MA, et al. J Clin Oncol. 2015 Mar 1;33(7):811. doi: 10.1200/JCO.2014.59.1370. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605855 No abstract available.

8

Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer.

Şendur MA, Aksoy S, Akıncı MB, Ozdemir N, Dede DŞ, Altundag K, Zengin N, Yalçın B. Şendur MA, et al. Future Oncol. 2015;11(6):905-7. doi: 10.2217/fon.15.6. Future Oncol. 2015. PMID: 25760972 No abstract available.

9

Denosumab: Excellent response of metastatic giant cell tumor of the bone.

Ulas A, Bulent Akinci M, Silay K, Sendur MA, Sener Dede D, Yalcin B. Ulas A, et al. J BUON. 2015 Mar-Apr;20(2):666-7. J BUON. 2015. PMID: 26011370 Free article. No abstract available.

10

Does Enzalutamide Really Reduce the Risk of Progression Compared With Bicalutamide in Patients With Castration-Resistant Prostate Cancer?

Şendur MA, Yalçın B. Şendur MA, et al. J Clin Oncol. 2017 Jan;35(1):122. doi: 10.1200/JCO.2016.68.0389. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 28034074 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters